Yes, this is exactly what the analysts have done with Microsoft (Goldman). They downgraded and depressed the price to an absurd level compared to the rest of the tech market. I see the opportunity here to make a really good return, but I don't have the funds available to buy a large enough chunk of the actual stock.
A 10% move up if I own the stock will make me $500 if I own the stock, or $5000 if I own the options. I recognize I am being greedy here, but I don't think buying an option is a lot different from buying the actual stock in a low priced biotech firm whose existence rides on the outcome of a drug trial. Both are going to be worthless if the gamble does not play out.

A 10% move up if I own the stock will make me $500 if I own the stock, or $5000 if I own the options. I recognize I am being greedy here, but I don't think buying an option is a lot different from buying the actual stock in a low priced biotech firm whose existence rides on the outcome of a drug trial. Both are going to be worthless if the gamble does not play out.
Comment